JNJ-26489112

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JNJ-26489112, covering 2012-04-05 to 2014-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy Volunteers [Phase 1]